Oxford Immunotec
(OXFD)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2018 | 12-2017 | 09-2017 | 06-2017 | 03-2017 | |
| Sales | 11,679 | -7,903 | 15,011 | 26,120 | 21,505 |
| Cost of Goods | 3,759 | -9,766 | 5,247 | 12,492 | 10,497 |
| Gross Profit | 7,920 | 1,863 | 9,764 | 13,628 | 11,008 |
| Operating Expenses | 16,043 | 12,451 | 27,881 | 31,868 | 18,461 |
| Operating Income | -7,364 | -11,354 | -17,870 | -17,748 | -6,956 |
| Interest Expense | 0 | 2,282 | 0 | 0 | 823 |
| Other Income | -759 | 28,568 | -1,405 | -1,476 | -246 |
| Pre-tax Income | -8,123 | 14,932 | -19,275 | -19,224 | -8,025 |
| Income Tax | 63 | 3,823 | 222 | -2,458 | 47 |
| Net Income Continuous | -8,186 | 11,109 | -19,497 | -16,766 | -8,072 |
| Net Income Discontinuous | -2,140 | -2,309 | 2,650 | N/A | N/A |
| Net Income | $-10,326 | $8,800 | $-16,847 | $-16,766 | $-8,072 |
| EPS Basic Total Ops | -0.40 | 0.42 | -0.70 | -0.74 | -0.36 |
| EPS Basic Continuous Ops | -0.32 | 0.50 | -0.81 | -0.74 | -0.36 |
| EPS Basic Discontinuous Ops | -0.08 | -0.10 | 0.11 | N/A | N/A |
| EPS Diluted Total Ops | -0.40 | 0.42 | -0.70 | -0.74 | -0.36 |
| EPS Diluted Continuous Ops | -0.32 | 0.50 | -0.81 | -0.74 | -0.36 |
| EPS Diluted Discontinuous Ops | -0.08 | -0.10 | 0.11 | N/A | N/A |
| EBITDA(a) | $-6,883 | $-10,849 | $-18,470 | $-16,618 | $-5,804 |